Table 1.
Study Subject Demographics
| |
Number (%) |
|
|
|---|---|---|---|
| Parameter | Flavocoxid | Placebo | P valuea |
| Gender | |||
| Female | 24 (80%) | 24 (82.8%) | .79 |
| Male | 6 (20%) | 5 (17.2%) | |
| Age (years) | |||
| Mean | 57.86 | 61.17 | .16 |
| Median | 58 | 63 | |
| Race | |||
| African-American | 7 (23.3%) | 6 (20.7%) | .56 |
| Caucasian | 22 (73.3%) | 23 (79.3%) | |
| Other | 1 (3.3%) | 0 | |
| BMI (kg/m2) | |||
| Mean (SEM) | 34.46 (1.59) | 29.90 (0.94) | .04 |
| Median | 32.73 | 30.36 | |
| Study completers | |||
| No | 6 (20%) | 7 (24.1%) | .75 |
| Yes | 23 (76.7%) | 22 (75.9%) | |
BMI, body mass index.
a
P values for continuous variables were generated by analysis of variance with treatment as a factor, whereas P values for categorical variables were derived by the χ2 test.